GW Seeing Traction With Epidiolex In The USA

MJ Biz report

It has seen brisk sales and new patient enrollments since the drug’s launch last November.

The company said Epidiolex sales were $68.4 million for the quarter that ended in June.

It also reported Epidiolex has been used by more than 12,000 patients coming from about 2,500 physicians since its launch

Full story

‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker

 

Go to Source
Author: Sean Hocking
Puffin’ On Some Good New?! Share Some…

About admin